CCM
CVAC

CAAS Capital Management’s CureVac CVAC Stock Holding History

CAAS Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-107,303
Closed -$748K – 716
2023
Q1 		$748K Buy
+107,303
New +$935K 0.04% 330
2021
Q2 		– Sell
-142,633
Closed -$13M – 1083
2021
Q1 		$13M Buy
+142,633
New +$13.8M 0.14% 175

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

CAAS Capital Management's CVAC Position: Q2 2023 in Review

CAAS Capital Management sold out of CureVac (CVAC) in Q2 2023, closing a stake of 107,303 shares — an estimated $748K sold.

CAAS Capital Management first reported a position in CVAC in Q1 2021 and held it in 2 quarters. The position peaked at $13M in Q1 2021. 88 funds tracked by Wall St. Rank hold CVAC as of Q2 2023.

  • CAAS Capital Management reported no remaining CureVac position as of Q2 2023 after selling out during the quarter.
  • CAAS Capital Management sold 107,303 CureVac shares in Q2 2023, an estimated $748K.
  • CAAS Capital Management first reported a position in CureVac in Q1 2021 and held it in 2 quarters.
  • CAAS Capital Management's CureVac position peaked at $13M in Q1 2021.
  • 88 funds tracked by Wall St. Rank held CureVac as of Q2 2023.

Based on CAAS Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.